BIOMAT Database Logo BIOMAT Database Logo

Splicing factors are differentially expressed in tumors. 2004

Natanja Kirschbaum-Slager, and Graziela M P Lopes, and Pedro A F Galante, and Gregory J Riggins, and Sandro J de Souza
Ludwig Institute for Cancer Research, São Paulo Branch, São Paulo, SP, Brazil.

Although alternative splicing of many genes has been found associated with different stages of tumorigenesis and splicing variants have been characterized as tumor markers, it is still not known whether these examples are sporadic or whether there is a broader association between the two phenomena. In this report we evaluated, through a bioinformatics approach, the expression of splicing factors in both normal and tumor tissues. This was possible by integrating data produced by proteomics, serial analysis of gene expression (SAGE) and microarray experiments. We observed a significant shift in the expression of splicing factors in tumors in both SAGE and microarray data, resulting from a large amount of experiments. We discuss that this supports the notion of a broader association between alternative splicing and cell transformation, and that splicing factors may be involved in oncogenic pathways.

UI MeSH Term Description Entries
D009363 Neoplasm Proteins Proteins whose abnormal expression (gain or loss) are associated with the development, growth, or progression of NEOPLASMS. Some neoplasm proteins are tumor antigens (ANTIGENS, NEOPLASM), i.e. they induce an immune reaction to their tumor. Many neoplasm proteins have been characterized and are used as tumor markers (BIOMARKERS, TUMOR) when they are detectable in cells and body fluids as monitors for the presence or growth of tumors. Abnormal expression of ONCOGENE PROTEINS is involved in neoplastic transformation, whereas the loss of expression of TUMOR SUPPRESSOR PROTEINS is involved with the loss of growth control and progression of the neoplasm. Proteins, Neoplasm
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014407 Tumor Cells, Cultured Cells grown in vitro from neoplastic tissue. If they can be established as a TUMOR CELL LINE, they can be propagated in cell culture indefinitely. Cultured Tumor Cells,Neoplastic Cells, Cultured,Cultured Neoplastic Cells,Cell, Cultured Neoplastic,Cell, Cultured Tumor,Cells, Cultured Neoplastic,Cells, Cultured Tumor,Cultured Neoplastic Cell,Cultured Tumor Cell,Neoplastic Cell, Cultured,Tumor Cell, Cultured
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers
D015972 Gene Expression Regulation, Neoplastic Any of the processes by which nuclear, cytoplasmic, or intercellular factors influence the differential control of gene action in neoplastic tissue. Neoplastic Gene Expression Regulation,Regulation of Gene Expression, Neoplastic,Regulation, Gene Expression, Neoplastic
D017398 Alternative Splicing A process whereby multiple RNA transcripts are generated from a single gene. Alternative splicing involves the splicing together of other possible sets of EXONS during the processing of some, but not all, transcripts of the gene. Thus a particular exon may be connected to any one of several alternative exons to form a mature RNA. The alternative forms of mature MESSENGER RNA produce PROTEIN ISOFORMS in which one part of the isoforms is common while the other parts are different. RNA Splicing, Alternative,Splicing, Alternative,Alternate Splicing,Nested Transcripts,Alternate Splicings,Alternative RNA Splicing,Alternative RNA Splicings,Alternative Splicings,Nested Transcript,RNA Splicings, Alternative,Splicing, Alternate,Splicing, Alternative RNA,Splicings, Alternate,Splicings, Alternative,Splicings, Alternative RNA,Transcript, Nested,Transcripts, Nested
D018076 DNA, Complementary Single-stranded complementary DNA synthesized from an RNA template by the action of RNA-dependent DNA polymerase. cDNA (i.e., complementary DNA, not circular DNA, not C-DNA) is used in a variety of molecular cloning experiments as well as serving as a specific hybridization probe. Complementary DNA,cDNA,cDNA Probes,Probes, cDNA
D018628 Gene Dosage The number of copies of a given gene present in the cell of an organism. An increase in gene dosage (by GENE DUPLICATION for example) can result in higher levels of gene product formation. GENE DOSAGE COMPENSATION mechanisms result in adjustments to the level GENE EXPRESSION when there are changes or differences in gene dosage. Gene Copy Number,Copy Number, Gene,Copy Numbers, Gene,Dosage, Gene,Dosages, Gene,Gene Copy Numbers,Gene Dosages,Number, Gene Copy,Numbers, Gene Copy

Related Publications

Natanja Kirschbaum-Slager, and Graziela M P Lopes, and Pedro A F Galante, and Gregory J Riggins, and Sandro J de Souza
Distinct calcium channels are generated by alternative splicing and are differentially expressed in the mammalian CNS.
July 1991, Neuron,
Natanja Kirschbaum-Slager, and Graziela M P Lopes, and Pedro A F Galante, and Gregory J Riggins, and Sandro J de Souza
Transcription factors are targeted by differentially expressed miRNAs in primates.
January 2012, Genome biology and evolution,
Natanja Kirschbaum-Slager, and Graziela M P Lopes, and Pedro A F Galante, and Gregory J Riggins, and Sandro J de Souza
Splicing factors differentially expressed in psoriasis alter mRNA maturation of disease-associated EDA+ fibronectin.
December 2017, Molecular and cellular biochemistry,
Natanja Kirschbaum-Slager, and Graziela M P Lopes, and Pedro A F Galante, and Gregory J Riggins, and Sandro J de Souza
Cancer Stem Cell Markers Are Differentially Expressed in Malignant Ovarian Germ Cell Tumors.
November 2023, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists,
Natanja Kirschbaum-Slager, and Graziela M P Lopes, and Pedro A F Galante, and Gregory J Riggins, and Sandro J de Souza
Alternative splicing generates two isoforms of the beta3-adrenoceptor which are differentially expressed in mouse tissues.
July 1999, British journal of pharmacology,
Natanja Kirschbaum-Slager, and Graziela M P Lopes, and Pedro A F Galante, and Gregory J Riggins, and Sandro J de Souza
E2F transcription factors are differentially expressed in murine gametes and early embryos.
October 2000, Mechanisms of development,
Natanja Kirschbaum-Slager, and Graziela M P Lopes, and Pedro A F Galante, and Gregory J Riggins, and Sandro J de Souza
Erratum to: Splicing factors differentially expressed in psoriasis alter mRNA maturation of disease-associated EDA+ fibronectin.
December 2017, Molecular and cellular biochemistry,
Natanja Kirschbaum-Slager, and Graziela M P Lopes, and Pedro A F Galante, and Gregory J Riggins, and Sandro J de Souza
Cryptic splicing sites are differentially utilized in vivo.
March 2008, The FEBS journal,
Natanja Kirschbaum-Slager, and Graziela M P Lopes, and Pedro A F Galante, and Gregory J Riggins, and Sandro J de Souza
Ectopeptidases are differentially expressed in hepatocellular carcinomas.
March 2004, International journal of oncology,
Natanja Kirschbaum-Slager, and Graziela M P Lopes, and Pedro A F Galante, and Gregory J Riggins, and Sandro J de Souza
Identification of differentially expressed microRNA in parathyroid tumors.
April 2011, Annals of surgical oncology,
Copied contents to your clipboard!